Press & Publications

November 2014: BlueStar Israel Equity Update

Our short term outlook for Israeli Global Equities remains neutral with a bullish bias as BIGI® has not broken through key technical resistance levels despite its sharp recovery from October’s lows.

Q4 2014: BlueStar Israel Equity Update

The S&P 500 index gained 1.10% in Q3 2014. MSCI EAFE and MSCI EM lost -5.80% and -3.40%, respectively. Israeli companies continued to list on U.S. exchanges during the quarter. Among the most notable were technology companies Mobileye, CyberArk and ReWalk. They will all be eligible to enter the BIGI and/or the BIGITech during the December 2014 rebalancing.

Investing in Israel - The Impact of Geopolitical Risk: A BlueStar BluePaper

This is an updated version of our inaugural “BluePaper,” originally published in February 2014, on a topic that is highly relevant to prospective investors in Israeli equities. We contrast the perception of risk in Israeli markets versus the reality of economic resilience and correlations with global rather than local events.

Read more

Our Mission

BlueStar Indexes is a wholly-owned subsidiary of BlueStar Global Investors LLC, a research-focused financial firm that specializes in the Israeli capital markets. BlueStar’s mission is to develop investment strategies that provide global institutional and retail investors efficient access to the full range of Israeli asset classes. Our initial focus is on Israeli stocks trading worldwide, but our research efforts span public equity, private equity/venture capital, fixed income, mutual fund and absolute return strategies....

Click here for more information about investing in Israel, the "Start-Up Nation"

Read more